BCL-W has a fundamental role in B cell survival and lymphomagenesis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Clinical Investigation

• Publication date

  2017-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI89486PMID 28094768PMCID PMC5272186
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.

  2016cited by this paper
• Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies.

  2016cited by this paper
• Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma

  2016cited by this paper
• Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies

  2016influential reference
• MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer

  2015cited by this paper
• The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

  2015cited by this paper
• MYC, Metabolism, and Cancer.

  2015cited by this paper
• Oncogenic mechanisms in Burkitt lymphoma.

  2014cited by this paper
• Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

  2014cited by this paper
• Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53

  2014cited by this paper
• Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer.

  2014cited by this paper
• miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma

  2013cited by this paper
• MYC, BCL2, BCL6 in DLBCL: impact for clinics in the future?

  2013cited by this paper
• An Integrated Encyclopedia of DNA Elements in the Human Genome

  2012cited by this paper
• Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.

  2012influential reference
• Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

  2012influential reference
• Endogenous Bcl-xL is essential for Myc-driven lymphomagenesis in mice.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

  2011cited by this paper
• An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737.

  2011cited by this paper
• PrimerBank: a PCR primer database for quantitative gene expression analysis, 2012 update

  2011cited by this paper
• miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.

  2011cited by this paper
• Tumor and Stem Cell Biology Cancer Research MicroRNA Biogenesis Is Required for Myc-Induced B-Cell Lymphoma Development and Survival

  2010cited by this paper
• Myc: Maestro of MicroRNAs.

  2010cited by this paper
• A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy

  2010cited by this paper
• miR-497 regulates neuronal death in mouse brain after transient focal cerebral ischemia.

  2010cited by this paper
• MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival.

  2010cited by this paper
• MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family

  2009cited by this paper
• Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.

  2009cited by this paper
• Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis

  2009cited by this paper
• In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas

  2008cited by this paper
• Myc's broad reach.

  2008influential reference
• Widespread microRNA repression by Myc contributes to tumorigenesis

  2008cited by this paper
• Selection against PUMA Gene Expression in Myc-Driven B-Cell Lymphomagenesis

  2008cited by this paper
• Stromal gene signatures in large-B-cell lymphomas.

  2008influential reference
• Gene Expression Omnibus ( GEO ) : Microarray data storage , submission , retrieval , and analysis

  2008cited by this paper
• Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells

  2008cited by this paper
• Adjusting batch effects in microarray expression data using empirical Bayes methods.

  2007cited by this paper
• Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.

  2007cited by this paper
• Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

  2007cited by this paper
• Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

  2007cited by this paper
• Bim is a suppressor of Myc-induced mouse B cell leukemia.

  2004cited by this paper
• Bcl-w is expressed in a majority of infiltrative gastric adenocarcinomas and suppresses the cancer cell death by blocking stress-activated protein kinase/c-Jun NH2-terminal kinase activation.

  2003cited by this paper
• Mdm2 haplo‐insufficiency profoundly inhibits Myc‐induced lymphomagenesis

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Negative regulation of the mammalian UV response by Myc through association with Miz-1.

  2002influential reference
• Bax Loss Impairs Myc-Induced Apoptosis and Circumvents the Selection of p53 Mutations during Myc-Mediated Lymphomagenesis

  2001cited by this paper
• A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.

  2001cited by this paper
• Tissue expression and subcellular localization of the pro-survival molecule Bcl-w

  2001cited by this paper
• Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during Lymphomagenesis

  2001cited by this paper
• Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1

  2001cited by this paper
• Bcl-w expression in colorectal adenocarcinoma

  1999cited by this paper
• Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

  1999cited by this paper
• Testicular degeneration in Bclw-deficient mice

  1998cited by this paper
• Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization.

  1998cited by this paper
• Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant.

  1998cited by this paper
• bcl-w, a novel member of the bcl-2 family, promotes cell survival.

  1996cited by this paper
• A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

  1995cited by this paper
• Down-regulation of bcl-2 by p53 in breast cancer cells.

  1994cited by this paper
• The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

  1988cited by this paper
• The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

  1985cited by this paper

• The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy

  2025cites this paper
• Copanlisib in combination with venetoclax in patients with relapsed/refractory mantle cell lymphoma

  2025cites this paper
• Discovery of Dual BCL-xL/BCL-w Degraders by Exploiting the Bis(sulfonyl)benzene Ring of ABT-263 as a Linkage Vector.

  2025cites this paper
• Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context

  2024cites this paper
• Contribution of A1 to macrophage survival in cooperation with MCL-1 and BCL-XL in a murine cell model of myeloid differentiation

  2024cites this paper
• Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma

  2024cites this paper
• CD52 knockdown inhibits aerobic glycolysis and malignant behavior of NSCLC cells through AKT signaling pathway

  2024cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• Chinese giant salamander Bcl-w: An inhibitory role in iridovirus-induced mitochondrial apoptosis and virus replication

  2023cites this paper
• BCL-W makes only minor contributions to MYC-driven lymphoma development

  2023cites this paper
• Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer.

  2023cites this paper
• Stayin' alive: BCL-2 proteins in the hematopoietic system.

  2022cites this paper
• Lessons from Using Genetically Engineered Mouse Models of MYC-Induced Lymphoma

  2022cites this paper
• BCL-2 protein family: attractive targets for cancer therapy

  2022cites this paper
• Sensitivity of Cutaneous T-Cell Lymphoma Cells to the Mcl-1 Inhibitor S63845 Correlates with the Lack of Bcl-w Expression

  2022influential citation
• An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia

  2022cites this paper
• MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging

  2022cites this paper
• What can we learn from mice lacking pro-survival BCL-2 proteins to advance BH3 mimetic drugs for cancer therapy?

  2022cites this paper
• The mitochondrial anti-apoptotic dependencies of hematologic malignancies: from disease biology to advances in precision medicine

  2022cites this paper
• Effects of miR-204 on apoptosis and inflammatory response of Clostridium perfringens beta2 toxin induced IPEC-J2 cells via targeting BCL2L2.

  2021cites this paper
• MYC regulates ribosome biogenesis and mitochondrial gene expression programs through its interaction with host cell factor–1

  2021cites this paper
• Prolactin Rescues Immature B Cells from Apoptosis-Induced BCR-Aggregation through STAT3, Bcl2a1a, Bcl2l2, and Birc5 in Lupus-Prone MRL/lpr Mice

  2021cites this paper
• Co-Operativity between MYC and BCL-2 Pro-Survival Proteins in Cancer

  2021cites this paper
• Genetic Events Inhibiting Apoptosis in Diffuse Large B Cell Lymphoma

  2021cites this paper
• BH3 Mimetics in Hematologic Malignancies

  2021cites this paper
• Targeting the BCL-2-regulated apoptotic pathway for the treatment of solid cancers

  2021cites this paper
• The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs

  2021cites this paper
• Bcl-xL Reduces Chinese Giant Salamander Iridovirus-Induced Mitochondrial Apoptosis by Interacting with Bak and Inhibiting the p53 Pathway

  2021cites this paper
• [Protective effect of iridoid glycosides of radix scrophulariae on endoplasmic reticulum stress induced by oxygen-glucose deprivation and reperfusion in vitro model].

  2020cites this paper
• Long Non-coding RNA X-Inactive Specific Transcript Mediates Cell Proliferation and Intrusion by Modulating the miR-497/Bcl-w Axis in Extranodal Natural Killer/T-cell Lymphoma

  2020cites this paper
• Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models

  2020cites this paper
• BCL-w: apoptotic and non-apoptotic role in health and disease

  2020cites this paper
• MicroRNA-148b enhances the radiosensitivity of B-cell lymphoma cells by targeting Bcl-w to promote apoptosis

  2020cites this paper
• BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell lines.

  2020cites this paper
• Insights about MYC and Apoptosis in B-Lymphomagenesis

  2020cites this paper
• The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways

  2020cites this paper
• MYC regulates ribosome biogenesis and mitochondrial gene expression programs through interaction with Host Cell Factor-1

  2020cites this paper
• WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target

  2020cites this paper
• Targeting the Bcl-2 Family in B Cell Lymphoma

  2019cites this paper
• 1-1-2019 Targeting the Bcl-2 Family in B Cell Lymphoma

  2019influential citation
• IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis

  2019cites this paper
• Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets

  2019cites this paper
• WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage

  2019cites this paper
• Bcl-2 Inhibition to Overcome Resistance to Chemo- and Immunotherapy

  2018cites this paper
• Novel Insights Into The Contribution Of Cellular Senescence To Cancer Therapy: Reversibility, Dormancy And Senolysis.

  2018cites this paper
• Hypermethylation of miR-205-5p by IR Governs Aggressiveness and Metastasis via Regulating Bcl-w and Src

  2018cites this paper
• Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells

  2018influential citation
• Non-Hodgkin and Hodgkin Lymphomas Select for Overexpression of BCLW

  2017influential citation
• The BCL-2 arbiters of apoptosis and their growing role as cancer targets

  2017cites this paper
• Long Noncoding RNA HOTAIR Modulates MiR-206-mediated Bcl-w Signaling to Facilitate Cell Proliferation in Breast Cancer

  2017cites this paper